A termék adatai:
| ISBN13: | 9781975199296 |
| ISBN10: | 1975199294 |
| Kötéstípus: | Puhakötés |
| Terjedelem: | 720 oldal |
| Méret: | 276x212 mm |
| Nyelv: | angol |
| 0 |
Témakör:
Cancer Chemotherapy, Immunotherapy, and Biotherapy
Kiadás sorszáma: Seventh
Kiadó: LWW
Megjelenés dátuma: 2024. augusztus 8.
Kötetek száma: Trade Paperback
Normál ár:
Kiadói listaár:
GBP 200.00
GBP 200.00
Az Ön ára:
84 042 (80 040 Ft + 5% áfa )
Kedvezmény(ek): 13% (kb. 12 558 Ft)
A kedvezmény csak az 'Értesítés a kedvenc témákról' hírlevelünk címzettjeinek rendeléseire érvényes.
Kattintson ide a feliratkozáshoz
Kattintson ide a feliratkozáshoz
Beszerezhetőség:
Még nem jelent meg, de rendelhető. A megjelenéstől számított néhány héten belül megérkezik.
Rövid leírás:
Focusing on individual patient needs, Cancer Chemotherapy, Immunotherapy and Biotherapy: Principles and Practice, Seventh Edition, provides thorough, comprehensive information from Drs. Bruce A. Chabner, Dan L. Longo, and an authoritative team of clinicians and scientists working at renowned cancer centers across the globe. It covers fundamental information about mechanism of action, pharmacokinetics, clinical toxicity, and drug interactions, all essential to the safe and effective use of the drug.
Hosszú leírás:
Focusing on individual patient needs, Cancer Chemotherapy, Immunotherapy and Biotherapy:&&&160; Principles and Practice, Seventh Edition, provides thorough, comprehensive information from Drs. Bruce A. Chabner, Dan L. Longo, and an authoritative team of clinicians and scientists working at renowned cancer centers across the globe. It covers fundamental information about mechanism of action, pharmacokinetics, clinical toxicity, and drug interactions, all essential to the safe and effective use of the drug.
- Features full-color illustrations, numerous tables for quick reference and new content that brings you fully up to date with the state of the art in all current cancer therapies
- Contains the latest information on immunotherapy and molecular targeted therapy as well as all drugs and biological agents, their mechanisms of action, interactions with other agents, toxicities, side effects, and mechanisms of resistance
- Reflects recent significant changes in cancer treatment, including new combination agents, new agents specifically related to CAR-T and checkpoint inhibitors, and new antibody conjugates
- Explains the rationale for use of drugs in specific schedules and combinations and offers guidelines for dose adjustment in specific situations